Jesse Paterson

Jesse Paterson is a seasoned professional in business development and strategic planning within the life sciences sector. Currently serving as Senior Director of Business Development at CQDM and as a member of the Board of Directors at both Neomabs Biotechnologies and giiant pharma inc., Jesse previously held the position of Director of Business Development at GlycoNet, where responsibilities included commercial strategy and partnership facilitation. Additional experience encompasses roles as Senior Advisor at CEIM, Business Development at Knight Therapeutics, and Associate Director of Licensing at Angiochem. Earlier career highlights include senior IP roles at Xanthus Pharmaceuticals and foundational experience as a Research Assistant/Lab Coordinator at McGill University. Jesse possesses a Master’s degree in Experimental Medicine from McGill University and a Bachelor’s degree in Honors Biochemistry from Concordia University.